Key findings • Sarcoidosis patients are prone to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, increased severity, morbidity and greater mortality of coronavirus disease 2019 ...

Sarcoidosis is a systemic inflammatory disorder of unknown etiology, characterized by the formation of noncaseating granulomas, multisystem involvement, intrathoracic (pulmonary and lymph node ...

The annual incidence of cardiac sarcoidosis is low, but increased awareness of this inflammatory condition has led to earlier ...

Both trials will report this year, but the SSc-ILD readout will only report interim data, as the trial is still enrolling patients. The Phase 3 data in pulmonary sarcoidosis is a much more ...

Discover how Temple Lung Center’s innovative clinical trials provide early access to breakthrough treatments and enhanced ...

“As we look to position efzofitimod as a potential chronic, maintenance therapy for patients with pulmonary sarcoidosis that can reduce or eliminate the use of oral corticosteroids, we are ...

Couple main things to keep in mind would be pulmonary fibrosis or sarcoidosis, which can have very long-term effect and damage to people's lung health and health in general." Q: What is ...

Listen to a short summary Read by Sharon R. Your browser does not support the audio element.Bridgette Ann Greer loved ...